OpenAI announced a new series of AI models built to help life sciences researchers work faster.
Why it matters:Biology research is increasingly computational, but scientists are drowning in data across fields like genomics, protein analysis and biochemistry.
Anthropic on Thursday released Claude Opus 4.7, a meaningful upgrade to its flagship AI model with better coding, sharper vision and a new ability to double-check its own work.
Why it matters: Anthropic publicly conceded that the new Opus model does not match the performance of Mythos, a highly advanced system that the company hasn't released to the public due to safety concerns.
BNY, America's oldest bank, has early access to OpenAI's and Anthropic's advanced cyber capability models, according to CEO Robin Vince, making the bank one of few vetted enterprises with early access.
Why it matters: Wall Street is working overtime to win the AI security race.
Anthropic users across online forums are raising the same complaint: Claude suddenly feels ... bad.
Why it matters: The backlash lands just as Anthropic is testing a more powerful model, Mythos — raising questions about whether cutting-edge AI is becoming less accessible even as it gets more capable.
Advances in AI's ability to take on novel scientific work are helping researchers move faster, connect siloed knowledge, and design treatments more efficiently, according to a new report from OpenAI's policy, research and sciences team shared first with Axios.
Why it matters: The life sciences have saved hundreds of millions of lives over the past century, but progress has slowed dramatically — even as the toughest diseases remain unsolved.
Hilbert, an AI startup rethinking how companies drive growth, raised a $28 million Series A led by Andreessen Horowitz, the startup told Axios exclusively.
Why it matters: Companies are pouring money into AI without always seeing returns, which Hilbert hopes to change by helping automate business decisions that drive growth.
Turion Space raised more than $75 million and plans to spend the money on improving its spacecraft production rates and its reconnaissance capabilities in orbit.
Why it matters: Turion is one of 14 companies recently selected by the Space Force to compete for work on the Andromeda program.
